COMMUNIQUÉS West-GlobeNewswire

La Croix-Rouge canadienne recueille des dons pour apporter de l’aide dans la foulée des séismes au Vénézuéla
25/06/2026
OTTAWA, Ontario, 25 juin 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a mis sur pied le Fonds de secours : Séismes au Vénézuéla afin de prêter assistance aux personnes éprouvées par la récente catastrophe. La [...]
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
25/06/2026
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced that it will report its second quarter 2026 financial and operating results on Thursday, July 30, 2026, [...]
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
25/06/2026
COPENHAGEN, Denmark, June 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia [...]
Ligand Announces Closing of Convertible Senior Notes Offering
25/06/2026
Opportunistic capital raise with proceeds used to enhance financial flexibility A portion of the proceeds to be used to purchase call spreads and to fund concurrent share repurchase intended to offset potential dilution [...]
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026
25/06/2026
MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, [...]
Medical Practice Pay Cools, But Hiring Pressure Holds Firm, New MGMA Report Finds
25/06/2026
Relentless hiring strain for medical assistants and a clear shift toward automation are reshaping how practices budget for 2027 Englewood, June 25, 2026 (GLOBE NEWSWIRE) -- Wages are easing. Hiring pressure isn't. And [...]
BioAdaptives Completes MyndSystem™ Platform with TruShield Certification of MyndRenew™, Securing Full WADA Compliance for Professional Athletes and Expanding Market Opportunity
25/06/2026
Certification validates the complete day-and-night neuro-performance and repair system, positioning the company for broader adoption across elite sports and high-value consumer segments LAS VEGAS, June 25, 2026 (GLOBE [...]
JellyFil Discloses 2026 Botanical Ingredient Sourcing, cGMP Manufacturing Standards, Caffeine Content, and Consumer Safety Considerations for Its Premium Gummy Dietary Supplement
25/06/2026
Florida-distributed gummy supplement brand discloses ingredient origins, manufacturing standards, and consumer safety considerations for 2026 Lakeland, FL, June 25, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada
25/06/2026
Building on Its Recent Acquisition of the CCX0722 Intellectual Property, Cosmos Health Owns the Technology Outright and Is Now Pursuing Patent Protection Across Four Major Healthcare Markets Within the $190+ Billion [...]
Xealth Survey Defines Digital Readiness Gaps Between Healthcare Executives and Physicians
25/06/2026
New market insights identify misaligned operational priorities in digital health and outline a framework for unification SEATTLE, June 25, 2026 (GLOBE NEWSWIRE) -- Xealth , the leader in digital health orchestration and [...]
First Stop Health Enhances Healthy Weight Program amid Growing GLP-1 Employee Demand and Employer Costs
25/06/2026
Program provides employers simple, clinically governed GLP-1 management options regardless of plan coverage CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- First Stop Health, the connected, whole-person virtual care platform [...]
Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale
25/06/2026
Le Dr Gerd Zettlmeissl est nommé président du conseil d’administration Lyon (France), le 25 juin 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]
Commure Named “Overall NLP Company of the Year” in 2026 AI Breakthrough Awards
25/06/2026
Recognition highlights Commure’s AI-native platform transforming healthcare operations at scale MOUNTAIN VIEW, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced [...]
Regenix Labs Announces Educational Guide on NAD+, Cellular Energy, and Healthy Aging
25/06/2026
New online guide explores NAD+, cellular energy production, and healthy aging research Regenix Labs logo. NEWARK, Del., June 25, 2026 (GLOBE NEWSWIRE) -- Regenix Labs LLC announces the availability of its educational [...]
Valneva Announces Successful Outcome of its Annual General Meeting
25/06/2026
Dr. Gerd Zettlmeissl is appointed as Chair of the Board of Directors Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that shareholders approved [...]
Two of Canada’s top athletes named Canadian Red Cross monthly giving ambassadors
25/06/2026
Alphonso Davies and Leylah Fernandez partnering with the Canadian Red Cross OTTAWA, June 25, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is pleased to announce Canadian men’s national soccer team captain Alphonso [...]
Deux athlètes d’élite du Canada deviennent ambassadeurs du programme de dons mensuels de la Croix-Rouge canadienne
25/06/2026
Alphonso Davies et Leylah Fernandez s’associent à la Croix-Rouge canadienne OTTAWA, 25 juin 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne est heureuse d’annoncer que la grande joueuse de tennis canadienne Leylah [...]
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
25/06/2026
ABO-101 is an investigational gene editing therapy designed to address the underlying disease biology of PH1 by reducing hepatic oxalate production Orphan Drug Designation (ODD) highlights the need for additional [...]

Pages